Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00392-022-02123-x.pdf
Reference35 articles.
1. Hauptman PJ, Swindle JP, Masoudi FA, Burroughs TE (2010) Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures. Circ Cardiovasc Qual Outcomes 3(2):204–211. https://doi.org/10.1161/CIRCOUTCOMES.109.880450
2. Roth GA, Poole JE, Zaha R, Zhou W, Skinner J, Morden NE (2016) Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation. J Am Coll Cardiol 67(9):1062–1069. https://doi.org/10.1016/j.jacc.2015.12.046
3. Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC (2015) Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival. Eur Heart J Cardiovasc Pharmacother 1(3):182–188. https://doi.org/10.1093/ehjcvp/pvv016
4. Martens P, Verbrugge FH, Nijst P, Bertrand PB, Dupont M, Tang WH et al (2017) Feasibility and association of neurohumoral blocker up-titration after cardiac resynchronization therapy. J Card Fail 23(8):597–605. https://doi.org/10.1016/j.cardfail.2017.03.001
5. Martens P, Dupont M, Mullens W (2020) Reduced occurrence of appropriate therapy for ventricular arrhythmias after beta-blocker uptitration following implant of a primary prevention CRT-defibrillator. Acta Cardiol 75(1):49–53. https://doi.org/10.1080/00015385.2018.1547469
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients;International Journal of Cardiology;2023-12
2. Quality improvement initiative to optimize heart failure treatment in patients with cardiac implantable electronic devices;Heart Rhythm O2;2023-05
3. The Role of Sacubitril/Valsartan and Gliflozins in Heart Failure with Reduced Ejection Fraction after Cardiac Resynchronization Therapy;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3